ENDRA Life Sciences- Warrants (12/05/2022) Current Cash

ENDRA Life Sciences- Warrants (12/05/2022) (NDRAW) currently reports a current cash of $1.7M as of June 2026. That compares with $1.8M in the prior-year period — down 3.8% year over year. Use the charts on this page to explore ENDRA Life Sciences- Warrants (12/05/2022)'s current cash history and peer comparisons.

ENDRA Life Sciences- Warrants (12/05/2022)'s current cash decreased from $1.8M to $1.7M — a 3.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ENDRA Life Sciences- Warrants (12/05/2022) reported $1.7M in current cash as of June 2026. That compares with $1.8M in the prior-year period — down 3.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ENDRA Life Sciences- Warrants (12/05/2022), and consider following NDRAW for alerts when major investors trade the stock.

ENDRA Life Sciences- Warrants (12/05/2022) is classified in the Technology sector. On current cash, it currently shows $1.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NDRAW with unrelated industries.